LMX1A as a prognostic marker in ovarian mucinous cystadenocarcinoma

American Journal of Clinical Pathology
Chih-Kung LinHerng-Sheng Lee

Abstract

This study aimed to evaluate the relationship of LMX1A and osteopontin (OPN) expression with clinicopathologic parameters for the 4 most common ovarian surface epithelial carcinomas. Both biomarkers were investigated immunohistochemically using tissue microarrays of 249 specimens including 91 serous cystadenocarcinomas, 56 mucinous cystadenocarcinomas, 64 endometrioid adenocarcinomas, 26 clear cell carcinomas, and 12 normal ovarian tissues. All 4 carcinomas showed significant expression of LMX1A and OPN. In addition, higher immunostaining scores and percentage of cells stained for LMX1A in mucinous cystadenocarcinomas correlated with T stage, American Joint Committee on Cancer clinical stage, poorer tumor differentiation, and poorer survival rate. In serous cystadenocarcinoma, higher percentage of staining for OPN and higher intensity or immunostaining scores for LMX1A correlated with poorer tumor differentiation. Thus, the expression of LMX1A may be an independent prognostic risk factor in mucinous cystadenocarcinoma and a helpful marker in evaluating this tumor's aggressiveness.

References

Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A W PartinD S Coffey
Nov 18, 1993·The New England Journal of Medicine·S A Cannistra
Feb 1, 2000·Trends in Genetics : TIG·O Hobert, H Westphal
Oct 2, 2001·CA: a Cancer Journal for Clinicians·R T GreenleeM Thun
Feb 5, 2002·Biochimica Et Biophysica Acta·G F Weber
Mar 20, 2002·Current Molecular Medicine·K A FurgerA F Chambers
May 16, 2002·Journal of Mammary Gland Biology and Neoplasia·A B Tuck, A F Chambers
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John O SchorgeSamuel C Mok
Mar 4, 2006·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Dec 16, 2006·Current Molecular Medicine·Goutam ChakrabortyGopal C Kundu
Jul 25, 2007·Nature Clinical Practice. Oncology·Usha Menon
Feb 9, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Irene VisintinGil Mor
Apr 10, 2008·International Journal of Cancer. Journal International Du Cancer·Hung-Cheng LaiMu-Hsien Yu
Dec 3, 2008·Pathology Oncology Research : POR·H ToyC Yavas
Aug 1, 2009·The Journal of Pathology·Chin-Yu LiuHung-Cheng Lai
May 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Victor V ChizhikovKathleen J Millen
Jun 16, 2010·Cancer Science·Motoki MatsuuraTsuyoshi Saito
Jan 1, 1998·Journal of Cellular Biochemistry·David T Denhardt, Masaki Noda

❮ Previous
Next ❯

Citations

Sep 17, 2013·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·G A GanttM F Kalady
Sep 7, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yue-Dong WangMin Hao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.